01—Abstract
Summary
Summary of the 10-K filed February 23, 2023. Cited figures are marked; the original filing is the authoritative source.
IDEX Corporation's 2022 Form 10-K reports a record year in sales, driven by robust demand, with net sales of $3,181.9 milliona, up 15% from $2,764.8 million in 2021.
Organic sales rose 13%, and net income attributable to IDEX was $586.9 millionb, up 31%. Diluted EPS was $7.71, compared with $5.88 in 2021. Adjusted EBITDA reached $884.2 million, up 16%, with an Adjusted EBITDA margin of 27.9%.
Management attributes the results to price capture amid inflation, execution, and the acquisition of Nexsight, KZValve and Muon Group during 2022. Cash flow from operations was $557.4 millionc, down from $565.3 million, as higher earnings were more than offset by increased working capital investment. Free cash flow was $489.4 million, or 79.2% of adjusted net income attributable to IDEX.
Cash and cash equivalents fell to $430.2 million, and total borrowings rose to $1,477.8 milliond. The company repurchased 795,423 shares for $148.1 million and paid $177.4 million in dividends. Investing outflows of $917.2 million reflected acquisitions, including Muon Group for $713.0 million in cash.
The Company stated it expects to refinance or repay its $100.0 million 3.20% Senior Notes due June 2023 using Revolving Facility capacity, and it reports a net available revolver borrowing capacity of $714.4 million. For 2023, management's stated priorities are foundational execution, building global teams, and capital deployment, with $1.5 billion deployed over the last two years on growth opportunities and a stated expectation of a high-quality acquisition pipeline. Credit ratings are BBB (S&P), Baa2 (Moody's) and BBB+ (Fitch), and the company reports compliance with its financial covenants.
02—Key points
Key Highlights
- Net sales of $3,181.9 million, up 15%; organic sales up 13%, with a 5% increase from acquisitions net of divestitures and a 4% unfavorable foreign currency impact.
- Net income attributable to IDEX of $586.9 million, up 31%; diluted EPS of $7.71 versus $5.88; adjusted diluted EPS of $8.12, up 18%.
- Adjusted EBITDA of $884.2 million, up 16%, with a margin of 27.9%, up 20 basis points.
- Operating cash flow of $557.4 million and free cash flow of $489.4 million, which was 79.2% of adjusted net income attributable to IDEX.
- Acquisitions in 2022 included Nexsight, KZValve and Muon Group; the sale of Knight produced a pre-tax gain of $34.8 million.
- Shareholder returns included $148.1 million in share repurchases and $177.4 million in dividends paid; $563.8 million of repurchase authorization remained at year-end.
- Total borrowings of $1,477.8 million at December 31, 2022, with covenant compliance and credit ratings of BBB (S&P), Baa2 (Moody's) and BBB+ (Fitch).
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2022, Idex kept $0.18.
- Revenue$3.18B100.0%
- Cost of revenue−$1.75B55.2%
- Gross profit$1.43B44.8%
- Operating costs−$675.5M21.2%
- Operating income$751.4M23.6%
- Interest, other & tax−$164.7M5.2%
- Net income$586.7M18.4%
Where FY2022 revenue went
$3.18B- Cost of revenue: $1.75B, 55% of revenue
- SG&A: $652.7M, 21% of revenue
- Net income: $586.7M, 18% of revenue
- R&D: $61.4M, 1.9% of revenue
- Interest, other & tax: $164.7M, 5.2% of revenue
Kept 18% as net income
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2022filed February 23, 2023Financial Statements
FY2022 against FY2021
| Line item | FY2022FY2021 | Change |
|---|---|---|
| Revenue | $3.18B$2.76B | +15.1% |
| Cost of Revenue | $1.75B$1.54B | +13.9% |
| Gross Profit | $1.43B$1.22B | +16.5% |
| R&D Expenses | $61.40M$50.10M | +22.6% |
| SG&A Expenses | $652.70M$578.20M | +12.9% |
| Operating Income | $751.40M$637.00M | +18.0% |
| Interest Expense | $40.70M$41.00M | −0.7% |
| Net Income | $586.70M$449.30M | +30.6% |
| EPS (Basic) | $7.74$5.91 | +31.0% |
| EPS (Diluted) | $7.71$5.88 | +31.1% |
| Shares Outstanding (Basic) | 75.70M76.00M | −0.4% |
| Shares Outstanding (Diluted) | 76.00M76.40M | −0.5% |
05—Questions
Frequently Asked Questions
How did IDEX perform financially in 2022?
Net sales rose 15% to $3,181.9 million, and net income attributable to IDEX rose 31% to $586.9 million. Diluted EPS was $7.71, compared with $5.88 in 2021. Operating income increased 18% to $751.4 million.
Did cash generation keep pace with earnings growth?
Not fully. Cash flows from operating activities decreased $7.9 million to $557.4 million because higher earnings were more than offset by an increased investment in working capital, including inventories, which rose $79.0 million. Free cash flow fell to $489.4 million from $492.6 million.
How is IDEX deploying capital and funding acquisitions?
In 2022 the company spent $945.6 million on acquisitions net of cash acquired, including Muon Group for $713.0 million, funded with cash on hand, Revolving Facility borrowings and Term Facility borrowings. It also repurchased $148.1 million of stock and paid $177.4 million in dividends. Management says it deployed $1.5 billion over the last two years and expects a high-quality acquisition pipeline in 2023.
What debt obligations and liquidity does IDEX have?
Total borrowings were $1,477.8 million at December 31, 2022. The company had $430.2 million of cash and cash equivalents and a net available Revolving Facility borrowing capacity of $714.4 million. It intends to refinance or repay its $100.0 million 3.20% Senior Notes due June 2023 using Revolving Facility capacity.
What are the key priorities for IDEX in 2023?
Management lists three priorities: foundational execution to drive efficiency, innovation and growth; building great global teams; and capital deployment into organic and inorganic opportunities. It anticipates 2023 organic investment will be in line with 2022 spending.
06—Continue